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stabilized knee prosthesis after a mean 25-month 
follow-up: Analysis of 110 prostheses” 
By William Pettya, MD, Gary Millerb, PhD, and Albert Bursteinc, PhD 
a Optetrak Design Team member, Chairman & CEO, Exactech, Inc. 
b Optetrak Design Team member, Executive VP, R&D, Exactech, Inc. 
c Optetrak Design Team member, Senior Scientist Emeritus, Hospital for Special Surgery. 
Total knee implants have evolved over time, taking 
advantage of new technologies. As changes are 
suggested and implemented, it is crucial to ensure 
that any potential modifications to existing designs 
maintain or improve  clinical outcomes. 
On initial view, the article by Thelu et al is 
proffered to be an evaluation of the effects of a 
knee system’s evolution on clinical outcomes in a 
meaningful way. The authors present a Level IV 
retrospective study of a continuous series of 110 
prostheses (106 patients) implanted between 2005 
and 2007, analyzed with a mean follow-up of 25 
months (range: 12-42 months) by an independent 
observer. Evaluation included International Knee 
Society (IKS) scores and radiological assessments 
conducted by three senior surgeons. The report 
states that the prostheses had “satisfactory 
mechanical axes”, with a mean Hip-Knee-Ankle 
(HKA) angle of 177.4°±4°. However, 25 prostheses 
(22%) presented with fixation interfaces evolving 
toward tibial implant loosening, and 24 (21%) had 
developed signs of patellofemoral problems. In 
fewer than 5 years, nine implants were revised for 
tibial loosening, three for patellofemoral instability, 
and one for patellofemoral pain. The authors 
conclude that design modifications from previous 
designs had altered clinical outcomes and, as a 
result, note they have suspended implantation of 
this prosthesis at their hospital. 
While we agree that the reported clinical 
outcomes are far from being satisfactory, we do 
question the arguments presented by Thelu et al. in 
this article. If we assume that the current article is 
based on the same cohort of patients presented for 
the general medicine thesis1 of Dr. Thelu (presided 
by Dr. Migaud) in December 2009, it is surprising the 
authors have omitted important study shortcomings 
that would assist readers in fully understanding the 
reported performance of the device in question. 
In the source thesis [1], Thelu stated that an 
instrument from an unrelated competitive total 
knee arthroplasty system was used for the ligament 
balancing step of the Optetrak PS knee components 
in flexion and extension. This instrument was used 
in 70% of the cases in the study. This deviation 
directly contradicts the Optetrak Instructions for 
Use, which clearly specifies Optetrak 
Comprehensive Knee System components should be 
implanted with the instrumentation specifically 
designed for this purpose, as significant inaccuracies 
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may result otherwise. For example, as demonstrated 
by Edwards et al. [[2] ], there are significant 
differences between true tibial insert thicknesses 
and nominal thicknesses in different knee systems. 
In other words, tibial insert thickness suggested 
using competitive system instrumentation may not 
indicate the appropriate thickness selection of an 
Optetrak tibial component, potentially leading to an 
incorrectly tensioned joint. 
In addition, Thelu et al. report satisfactory 
reproduction of the mechanical axis with a mean 
HKA angle of 177.4°±4°. However, analysis of the 
HKA angles reported in the source thesis [[1] ] for 
each individual case of tibial loosening results in an 
actual mean HKA angle of 174q for patients 
associated with confirmed tibial loosening. It would 
have been appropriate for the authors to disclose 
the implications of this residual varus misalignment 
in those patients with loosening. Observational data 
from numerous series [[3] -[12] ] have led to the 
understanding that a neutral mechanical axis is 
important in providing durability and good function 
following surgery, and that wear and premature 
failure can occur if the total knee replacements are 
mechanically aligned in varus. 
Finally, the source thesis [[1] ] stated “…the 
cementation is of paramount importance and a 
sensible step, requiring accurate technique in order 
to ensure an appropriate fixation. The author 
cannot ensure that in our study, every steps of the 
cementation were perfectly done; which may be in 
part responsible for the loosening of the tibial 
implant.” However, the authors do not discuss this 
in describing the observed performance problems 
they report. 
Cementation technique is crucially important for 
any cemented knee system. Figure 3B of the article 
indicates a total absence of cement extrusion in the 
medial and lateral undercuts of the tibial tray, 
leading to serious questions about effective cement 
mantle pressurization. The lack of proper 
pressurization indicated by this illustration is very 
significant and should have been properly 
recognized in the discussion section. 
We propose that Thelu et al. should have 
discussed in detail the effects of their improper 
implantation technique (i.e., use of non-approved 
instrumentation, significant residual implant varus 
associated with loosening, and questionable 
cementation technique) on the clinical outcomes 
reported. 
Instead, the authors attributed potential causes 
of poor results and failure to the design 
modifications used to create the Optetrak implants 
as compared to its predecessor, the Insall Burstein II 
(IB II) system. Toward this end, we respectfully 
maintain that the authors have significantly 
misinterpreted basic biomechanical fundamentals in 
their analysis, leading to erroneous and incorrect 
assertions. 
One potential cause of failure cited by the 
authors is the Optetrak tibial spine being higher 
than the tibial spine of the IB II potentially causing 
higher stresses at the tibial bone-implant interface. 
While the Optetrak tibial insert spine is slightly 
higher overall than the IB II spine to inhibit femoro-
tibial subluxation, increased loading of the tibial 
baseplate-cement interface is a result of elevation 
of the contact point between the femoral cam and 
posterior part of the tibial insert spine, not simply a 
function of the overall spine height. The Optetrak 
cam-post contact point is actually lower than the 
contact point for the IB II, resulting in reduction of 
the stress at the tibial baseplate-cement interface. 
The lower contact point is the result of optimizing 
the location of the femoral cam relative to the 
condyles and using a more elongated shape. Thus 
the outcome to be associated with the higher 
Optetrak PS tibial insert spine should include a 
higher jumping height, not increased stress at the 
implant-cement interface. 
Second, the authors continuously describe the 
Optetrak design as “ultra-congruent,” attributing 
this feature as a possible cause of loosening. 
However, in fact, the Optetrak is not an “ultra-
congruent” device. Typically, “ultra-congruent” 
refers to knee systems with high sagittal plane 
congruency. In the sagittal plane, the Optetrak knee 
system is less congruent than the IB II in extension 
(0.67 for the Optetrak versus 0.90 for the IB II) and 
comparably congruent in flexion (0.39 for Optetrak 
versus 0.43 for IB II). Optetrak increased congruency 
as compared to the IB II (0.96 vs. 0.94) should refer 
to frontal congruency, not sagittal congruency. As 
shown by Bartel et al. [[13] ], a higher frontal 
congruency decreases contact stresses on the 
UHMWPE tibial insert. The frontal congruency of the 
Optetrak, a patented technology, provides proven 
advantages in terms of reduced wear rates, as 
established by Li [[14] ] and Angibaud [[15] ]. The 
authors’ depiction of the Optetrak as an ultra-
congruent system is incorrect and misleading. 
Third, the authors state the wave-shaped profile 
of the rotating-bearing Optetrak system tibial 
inserts could increase stress. This statement directly 
contradicts the principles of the wave design, which 
predictably distributes load over a larger area 
around the center of the tray to avoid the type of 
radial edge-loading potential observed in devices 
featuring flat-on-flat bearings. 
The authors also repeatedly describe the finned 
(or “winged”) Optetrak tibial baseplate stem as 
short and small, notably depicting it as shorter and 
smaller than its rectangular Optetrak counterpart. 
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In actuality, the two baseplates feature stems of the 
exact same length. Considering both the frontal and 
sagittal planes, the “winged” baseplate stem also 
features a larger overall surface area than the 
rectangular stem. 
In addition to the incorrect implantation 
technique and misrepresented implant design 
parameters, the article misrepresents a study 
published in the Journal of Arthroplasty by Dr. 
Robinson [[16]]. While Robinson reported 42% of the 
Optetrak tibias in his study displayed radiolucent 
lines, he also states no knee was radiographically 
loose, an important contrasting omission by Thelu et 
al.
Significantly, other studies report good clinical 
outcomes for the Optetrak system, which has been 
in use for 15 years [[17] -[19] ]. The conclusions of 
Thelu et al. regarding patellofemoral complications 
contradict a recent study by Ehrhardt and co-
workers from HSS concluding design modifications 
for the posterior-stabilized Optetrak knee have 
successfully reduced patellofemoral complications, 
including patellar clunk and patellar fracture, in 
comparison to the IB II. In addition, Gougeon 
recently reported a survival rate of 99.5% with the 
same implant system and follow-up times [[20] ]
similar to those reported by Thelu et al. 
In summary, the authors investigated the effects 
of a knee system’s evolution on clinical outcomes 
and concluded progressive design modifications from 
previous designs altered clinical outcomes. It is 
regretful the authors omitted the limitations and 
shortcomings of the source thesis [[1]]. By doing so, 
the authors produce a biased conclusion that will 
mislead readers. 
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